La piattaforma ACC di ricerca preclinica per l’oncologia di precisione

Title

Code

Piattaforma ACC

Type

Osservazionale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366760

katia.scotlandi@ior.it

Scotlandi Katia, MSc

Director

Laboratory of Oncology Research and Functional Genomics

Operational unit that carry out the study

complex unit

Laboratorio di Ricerca oncologica e genomica funzionale

Director

Scotlandi Katia, MSc

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Piattaforma ACC

Friday 3 November 2023, 10:32

PG0016338_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

La piattaforma ACC di ricerca preclinica per l’oncologia di precisione

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

La piattaforma ACC di ricerca preclinica per l’oncologia di precisione

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in